Watch for Cabenuva, a New Monthly Injectable for HIV

Cabenuva (cabotegravir/rilpivirine) will be the first MONTHLY injectable treatment for adults living with HIV.

Cabenuva comes in a kit containing one vial of cabotegravir and one vial of rilpivirine. Each med is injected separately into the buttock (gluteal) muscle at the same visit.

Expect Cabenuva to be an option for patients with stable HIV who've been on a daily oral HIV regimen (Biktarvy, Triumeq, etc) and prefer less frequent dosing.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote